Elixirr International (ELIX) H2 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 TU earnings summary
8 Oct, 2025Executive summary
Finished FY24 strongly, with results expected above market expectations.
Achieved record revenue for January 2025, indicating continued momentum into the new year.
Financial highlights
FY24 revenue expected to exceed £111 million, above the guidance range of £108–£111 million.
Adjusted EBITDA margin anticipated at approximately 28%, within the 27–29% guidance range.
Adjusted EBITDA projected at around £31 million.
Cash balances at year-end approximately £7.5 million, with full repayment of debt drawn for the Hypothesis Group acquisition.
Outlook and guidance
FY24 results continue the track record of exceeding the Rule of 40 (revenue growth plus Adjusted EBITDA margin > 40%).
Full year FY24 results to be announced on 28 April 2025.
Latest events from Elixirr International
- Revenue, EBITDA, and dividend growth drive record performance and FTSE 250 ambitions.ELIX
H2 2025 TU22 Jan 2026 - Record H1 2024 revenue and EBITDA growth, strong cash flow, and positive FY24 outlook.ELIX
H1 202419 Jan 2026 - Record FY24 growth, US expansion, and Main Market move set stage for continued outperformance.ELIX
H2 20247 Jan 2026 - 35% revenue and 42% EBITDA growth, Main Market move, and TRC deal drive strong outlook.ELIX
H1 202521 Dec 2025 - Record revenue growth and strong margins in H1 2025, with a confident outlook for FY 2025.ELIX
H1 2025 TU8 Oct 2025